An experiential analysis of the SARS Cov-2 infection stages and therapeutics from a Covid-19 survivor

Show simple item record

dc.contributor.author Kimatu, Josphert N.
dc.contributor.author King'esi, Patriciah K.
dc.date.accessioned 2021-07-02T11:47:42Z
dc.date.available 2021-07-02T11:47:42Z
dc.date.issued 2021-04
dc.identifier.citation International Journal Of Pharmaceutical And Phytopharmacological Research, 11(2),74-79 en_US
dc.identifier.issn 2249-6084
dc.identifier.issn 2250-1029
dc.identifier.uri https://eijppr.com/article/an-experiential-analysis-of-the-sars-cov-2-infection-stages-and-therapeutics-from-a-covid-19-survivo-tazzdffuggakijb
dc.identifier.uri http://repository.seku.ac.ke/handle/123456789/6281
dc.description DOI: https://doi.org/10.51847/6eRs6Z3kWb en_US
dc.description.abstract In late 2019, there was an emergence of a SARS-CoV-2 strain of the coronavirus with the first reports coming from Wuhan China. This strain has since spread and mutated across the world causing a pandemic as of June 2021. The SARS-CoV-2 causes a disease called COVID-19 in the human body. The progression of the disease symptoms has not been systematically illustrated fully. This paper attempts to logically give a scientific guide on the progressive development of the symptoms experienced by most COVID-19 patients. The study is based on a personal infection of SARS CoV-2, symptom evaluation, medication, and recovery from COVID-19. It also looks comparatively at other literature and patients’ experiences. The patient data was collected during the second SARS-CoV-2 wave in Kenya with reports of the South Africa SARS CoV-2 strain being reported in the country. The study recommends a continuous pathogenies evaluation of the subsequent SAR CoV-2 variants infection pathways. This shall decipher the main attack models of the new variants and thereafter in the development and validation of COVID-19 vaccines. en_US
dc.language.iso en en_US
dc.subject Mutation en_US
dc.subject Corona en_US
dc.subject Kenya en_US
dc.subject Vaccines en_US
dc.subject Immunity en_US
dc.subject Pandemic en_US
dc.title An experiential analysis of the SARS Cov-2 infection stages and therapeutics from a Covid-19 survivor en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search Dspace


Browse

My Account